Over the past several years RGCB has set a high standard of research
and development in selected areas of Biotechnology. The institute has
made impressive advances in areas of disease biology and its track
record in creating trained competent manpower in biotechnology through
its innovative PhD program has been well appreciated.
To take these basic advances forward and to create an environment
where knowledge generated through fundamental research in disease
biology and molecular medicine gets translated to innovative new tools
and products, the Prime Minister's Office announced a grant of Rupees
100 crores to allow the further development of RGCB.
Subsequent to this the Department of Biotechnology approved an SFC
that will allow RGCB to create a specialized ecosystem called
Bio-Innovation Center (BIC). This will be a unique knowledge centre and
hub for mid and high level innovation founded on deep and advanced level
technical platforms, multidisciplinary cores that will seed growth and
innovation. Following this the Government of Kerala responded by
allotting at no cost 20 acres of land in the heart of Trivandrum City
close to all major medical institutions, to build this new venture.
The key goals of BIC in the first phase (12th Plan) shall include
programs to evolve itself into a hub for research on vaccines &
immunotherapeutics, molecular diagnostics and biomarkers, chemical &
nano-biotechnology and tropical disease biology. Such R&D strategies
will also be accompanied by programs that impart international quality
biotechnology education and training to graduates and postgraduates in
science, engineering and medicine.
In the next phase the BIC will strive to begin a state of the art
"Advanced Center for Molecular & Cellular Therapeutics" that will
involve a 75 bed hospital jointly run with the Regional Cancer Centre,
which will offer cutting edge technologies, therapies and clinical
trials for cancer vaccines, immunotherapeutics and in addition therapies
such as stem cell replacements, gene therapy, molecular tumor targeting
and imaging. The second phase will also offer to investors,
entrepreneurs, biotech and bio-pharma companies a state- of- the-art
research facility incorporating a unique "test and prove platform" which
will provide all pre-clinical, analytical, toxicological and biological
assays to validate a biotech or biological products besides offering
shared facilities and start-up technological and business development
Incubators. This no doubt will contribute to the development of
biotechnology in the country.
Considering the delays that will be expected in construction of new
buildings and not wanting to compromise on the effects of such delays to
scientific output, the RGCB Governing Council approved a transit
facility to install major equipment and creation of new laboratories.
This was all the more important in view of critical space shortage in
the main RGCB campus. The transit facility located at the KINFRA Film
and Video Park in Thiruvananthapuram now houses the RGCB's Bio-Imaging,
Genomics and Laboratory Medicine & Molecular Diagnostics core facilities
in addition to laboratories for Chemical Biology and Tropical Disease
Biology. This facility also hosts research programs of the Srinivasa
Ramanujam Institute for Basic Sciences, a R&D institution of the Kerala
State Council for Science, Technology and Environment (KSCSTE),
Government of Kerala. RGCB and KSCSTE have signed a MoU to this effect
which provides to RGCB manpower and research funds for hosting and
jointly running common research programs.
Rajiv Gandhi Centre for Biotechnology (RGCB), Thycaud Post,
Poojappura, Thiruvananthapuram - 695 014, Kerala, India +91-471-2529400
| 2347975 | 2348753 +91-471-2348096